LONDON, England, July 26 -- Analytical Methods, a peer-reviewed journal from the Royal Society of Chemistry that says it features an early applications of new analytical methods with clear societal impact, published research articles on the following topics in its Aug. 7, 2024, edition (Vol. 16, Issue 29): * Photonic crystal gas sensors based on metal-organic frameworks and polymers * Recent progress on DNAzyme-based biosensors for pathogen detection * Detection of GSH with a dual-mode biosen more PR

WASHINGTON, July 26 (TNSrep) -- The U.S. Department of Agriculture's Economic Research Report (No. ERR-334) on July 25, 2024: Here are excerpts: * * * The milk production segment of the U.S. dairy industry has experienced significant change over the past two decades. This study uses USDA's Agricultural Resource Management Survey (ARMS) dairy version data (and other USDA data) to examine changes in farm structure, production costs, and technology adoption and to compare dairy farms by size and more PR

WASHINGTON, July 26 -- The Federal Communications Commission issued the following dissent on July 25, 2024, by Commissioner Nathan Simington on an action entitled "Disclosure and Transparency of Artificial Intelligence-Generated Content in Political Advertisements, Notice of Proposed Rulemaking" (Docket No. 24-211). * * * Generative artificial intelligence is certainly a buzzy topic. But, absent the compelling force of an ongoing crisis or a situation worsening moment-to-moment, the worst time more PR

WILMINGTON, Delaware, July 26 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * FDA Advisory Committee reviewed IMFINZI(R) (durvalumab) for treatment of resectable non-small cell lung cancer based on AEGEAN Phase III trial results * * * The Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) acknowledged that AstraZeneca's IMFINZI(R) (durvalumab) met the primary endpoint of event-free survival (EFS) in the treatment of r more PR

WASHINGTON, July 25 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated July 23, 2024, from the International Dairy Foods Association: * * * To: Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 RE: Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance: Appendix 1 [Docket No. FDA-2016-D-2343] * * * The International D more ST

WILMINGTON, Delaware, July 26 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * First immunotherapy regimen before and after surgery to extend survival in bladder cancer * * * Positive high-level results from the NIAGARA Phase III trial showed AstraZeneca's IMFINZI(R) (durvalumab) in combination with chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of event-free survival (EFS) and the key s more PR

CHICAGO, Illinois, July 26 -- The Journal of Food Science, a journal that says it serves as an international forum for food science from the Institute of Food Technologists, published research articles on the following topics in its July 2024 edition (Vol. 89, Issue 7): REVIEW ARTICLE: * Concise Reviews and Hypotheses in Food Science - 10-hydroxy decanoic acid, trans-10-hydroxy-2-decanoic acid, and sebacic acid: Source, metabolism, and potential health functionalities and nutraceutical applic more PR

HOBOKEN, New Jersey, July 26 -- Maternal and Child Nutrition, a peer-reviewed journal that says it features nutrition, maternal, child, paediatrics, pediatrics, infant, baby, neonate, food, dietetics, obstetrics, midwifery and health, published research articles on the following topics in its July 2024 edition (Vol. 20, Issue 3): REVIEW ARTICLES: * Maternal anaemia prevention and control in China: A policy review * Effects of short birth interval on child malnutrition in the Asia-Pacific regi more PR